Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Pantoprazole Following Upper GI Bleed
NCT02235311Terminated
- Sponsor
- University of Missouri
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of pantoprazole in upper gastrointestinal bleeding (UGIB) and peptic ulcer disease (PUD) (2 arms), sponsored by University of Missouri. Primary endpoint: Ulcer Healing at 8 weeks. Started Oct 2014; status: terminated.
02
Drugs
pantoprazole
03
Conditions
upper gastrointestinal bleeding (UGIB)peptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT02235311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02235311.